POLG-related mitochondrial disorders
Sep. 12, 2024
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
(A) H & E (400X). (B) Nuclear atypia and increased mitotic activity (circled). (C) Prominent microvascular proliferation. (D) Region of focal necrosis with palisading tumor cells. (E) Positive immunohistochemical stain for mutant IDH1-R132H protein. (F) Retained nuclear ATRX expression. (Contributed by: Dr. Mark Curtis.)